Obama Budget Calls for Sustained Investment in Research

In his State of the Union address last month, President Barack Obama reaffirmed the prioritization of science and technology in his plans for the nation’s future. The President’s new economic plan calls for maintaining a commitment to funding research and development that can improve our quality of life.

Obama budget calls for sustained investment in research

F1000 Launches Open Access Publishing for Biology and Medicine

This week, the Faculty of 1000 (F1000), announced F1000 Research, a new fully Open Access publishing program across biology and medicine that will launch later this year [1]. F1000 Research is intended to address the major issues afflicting scientific publishing today: timely dissemination of research, peer review, and sharing of data.

F1000 Research

Bath Salts Case Underscores Dangers of Legal Drugs

A New Orleans woman recently lost an arm to necrotizing fasciitis — the so-called “flesh-eating bacteria” — after injecting a drug called “bath salts,” according to a case study report in the medical journal Orthopedics [1]. She presented with cellulitis, a skin infection, two days after attending a party at which she injected the drug. The infection initially responded to administered antibiotics, but then worsened. The woman lost not only her arm, but her breast and a large portion of her chest wall to amputation. The significant removal of tissue was necessary to prevent the spread of the bacteria.

Controversial Anti-obesity Ads Aim to Reduce Childhood Obesity

A new series of billboard and television ads is outraging Georgians, who object to the “Stop Sugarcoating It, Georgia” campaign being run by the Children’s Healthcare of Atlanta pediatric hospital. The ads depict overweight and obese children in a variety of settings, and are meant to shock parents into action.

Stop childhood obesity

Novartis Issues Recall Because of Broken, Mixed Medicines

Novartis said on Sunday that it is voluntarily recalling certain lots of over-the-counter products because they might contain broken or stray tablets from other products [1]. The recall comes following consumer complaints of chipped and broken pills, and inconsistent bottle packaging line clearance practices (meaning cleaning and clearance operations that are performed when a product or strength change occurs during medicine packaging) that may have possibly resulted in mixed tablets.

Excedrin Bufferin NoDoz Gas-X